Condition
Autistic Behavior
Total Trials
5
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Withdrawn2
Completed1
Active Not Recruiting1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02677051Phase 2Active Not Recruiting
Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism
NCT04100863Withdrawn
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Autism
NCT03724136Not ApplicableEnrolling By Invitation
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
NCT03829878Phase 2Withdrawn
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)
NCT03206996Not ApplicableCompleted
Exposure Therapy for Auditory Sensitivity in Autism
Showing all 5 trials